3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS
The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula (I), and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula (I) to treat cognitive impairment associated with Parkinson's disease o...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HAO, JUNLIANG SCHAUS, JOHN MEHNERT BEADLE, CHRISTOPHER DAVID WOLFANGEL, CRAIG DANIEL KRUSHINSKI, JOSEPH HERMAN, JR COATES, DAVID ANDREW REINHARD, MATTHEW ROBERT |
| description | The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula (I), and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula (I) to treat cognitive impairment associated with Parkinson's disease or schizophrenia.
L'invention concerne certains composés de 3,4-dihydroisoquinoléin-2(1H)-yle, notamment des composés de formule (I), et des compositions pharmaceutiques correspondantes. L'invention concerne en outre des procédés d'utilisation d'un composé de formule (I) pour traiter la déficience cognitive associée à la maladie de Parkinson ou à la schizophrénie. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2912849C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2912849C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2912849C3</originalsourceid><addsrcrecordid>eNrjZNA01jHRdfH0iHQJ8vcM9g8M9fTz9_H00zXSMPTQ1I30UXD29w3wD_VzCeZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjkaWhkYWJpbOxoRVAAB-iSM8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS</title><source>esp@cenet</source><creator>HAO, JUNLIANG ; SCHAUS, JOHN MEHNERT ; BEADLE, CHRISTOPHER DAVID ; WOLFANGEL, CRAIG DANIEL ; KRUSHINSKI, JOSEPH HERMAN, JR ; COATES, DAVID ANDREW ; REINHARD, MATTHEW ROBERT</creator><creatorcontrib>HAO, JUNLIANG ; SCHAUS, JOHN MEHNERT ; BEADLE, CHRISTOPHER DAVID ; WOLFANGEL, CRAIG DANIEL ; KRUSHINSKI, JOSEPH HERMAN, JR ; COATES, DAVID ANDREW ; REINHARD, MATTHEW ROBERT</creatorcontrib><description>The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula (I), and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula (I) to treat cognitive impairment associated with Parkinson's disease or schizophrenia.
L'invention concerne certains composés de 3,4-dihydroisoquinoléin-2(1H)-yle, notamment des composés de formule (I), et des compositions pharmaceutiques correspondantes. L'invention concerne en outre des procédés d'utilisation d'un composé de formule (I) pour traiter la déficience cognitive associée à la maladie de Parkinson ou à la schizophrénie.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170530&DB=EPODOC&CC=CA&NR=2912849C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170530&DB=EPODOC&CC=CA&NR=2912849C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HAO, JUNLIANG</creatorcontrib><creatorcontrib>SCHAUS, JOHN MEHNERT</creatorcontrib><creatorcontrib>BEADLE, CHRISTOPHER DAVID</creatorcontrib><creatorcontrib>WOLFANGEL, CRAIG DANIEL</creatorcontrib><creatorcontrib>KRUSHINSKI, JOSEPH HERMAN, JR</creatorcontrib><creatorcontrib>COATES, DAVID ANDREW</creatorcontrib><creatorcontrib>REINHARD, MATTHEW ROBERT</creatorcontrib><title>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS</title><description>The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula (I), and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula (I) to treat cognitive impairment associated with Parkinson's disease or schizophrenia.
L'invention concerne certains composés de 3,4-dihydroisoquinoléin-2(1H)-yle, notamment des composés de formule (I), et des compositions pharmaceutiques correspondantes. L'invention concerne en outre des procédés d'utilisation d'un composé de formule (I) pour traiter la déficience cognitive associée à la maladie de Parkinson ou à la schizophrénie.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNA01jHRdfH0iHQJ8vcM9g8M9fTz9_H00zXSMPTQ1I30UXD29w3wD_VzCeZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjkaWhkYWJpbOxoRVAAB-iSM8</recordid><startdate>20170530</startdate><enddate>20170530</enddate><creator>HAO, JUNLIANG</creator><creator>SCHAUS, JOHN MEHNERT</creator><creator>BEADLE, CHRISTOPHER DAVID</creator><creator>WOLFANGEL, CRAIG DANIEL</creator><creator>KRUSHINSKI, JOSEPH HERMAN, JR</creator><creator>COATES, DAVID ANDREW</creator><creator>REINHARD, MATTHEW ROBERT</creator><scope>EVB</scope></search><sort><creationdate>20170530</creationdate><title>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS</title><author>HAO, JUNLIANG ; SCHAUS, JOHN MEHNERT ; BEADLE, CHRISTOPHER DAVID ; WOLFANGEL, CRAIG DANIEL ; KRUSHINSKI, JOSEPH HERMAN, JR ; COATES, DAVID ANDREW ; REINHARD, MATTHEW ROBERT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2912849C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HAO, JUNLIANG</creatorcontrib><creatorcontrib>SCHAUS, JOHN MEHNERT</creatorcontrib><creatorcontrib>BEADLE, CHRISTOPHER DAVID</creatorcontrib><creatorcontrib>WOLFANGEL, CRAIG DANIEL</creatorcontrib><creatorcontrib>KRUSHINSKI, JOSEPH HERMAN, JR</creatorcontrib><creatorcontrib>COATES, DAVID ANDREW</creatorcontrib><creatorcontrib>REINHARD, MATTHEW ROBERT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HAO, JUNLIANG</au><au>SCHAUS, JOHN MEHNERT</au><au>BEADLE, CHRISTOPHER DAVID</au><au>WOLFANGEL, CRAIG DANIEL</au><au>KRUSHINSKI, JOSEPH HERMAN, JR</au><au>COATES, DAVID ANDREW</au><au>REINHARD, MATTHEW ROBERT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS</title><date>2017-05-30</date><risdate>2017</risdate><abstract>The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula (I), and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula (I) to treat cognitive impairment associated with Parkinson's disease or schizophrenia.
L'invention concerne certains composés de 3,4-dihydroisoquinoléin-2(1H)-yle, notamment des composés de formule (I), et des compositions pharmaceutiques correspondantes. L'invention concerne en outre des procédés d'utilisation d'un composé de formule (I) pour traiter la déficience cognitive associée à la maladie de Parkinson ou à la schizophrénie.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2912849C |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T13%3A34%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HAO,%20JUNLIANG&rft.date=2017-05-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2912849C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |